{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:53:12Z","timestamp":1781657592659,"version":"3.54.5"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-71935-6","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T17:43:46Z","timestamp":1776361426000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transport and inhibition mechanisms of human glycine transporter 2"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0612-3936","authenticated-orcid":false,"given":"Wenming","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanzhi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zirui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2814-8976","authenticated-orcid":false,"given":"Junwen","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mulin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9851-0065","authenticated-orcid":false,"given":"Jing-Xiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"71935_CR1","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.tips.2014.05.006","volume":"35","author":"RJ Vandenberg","year":"2014","unstructured":"Vandenberg, R. J., Ryan, R. M., Carland, J. E., Imlach, W. L. & Christie, M. J. Glycine transport inhibitors for the treatment of pain. Trends Pharm. Sci. 35, 423\u2013430 (2014).","journal-title":"Trends Pharm. Sci."},{"key":"71935_CR2","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/nrd3893","volume":"12","author":"RJ Harvey","year":"2013","unstructured":"Harvey, R. J. & Yee, B. K. Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain. Nat. Rev. Drug Discov. 12, 866\u2013885 (2013).","journal-title":"Nat. Rev. Drug Discov."},{"key":"71935_CR3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0165-6147(02)02138-7","volume":"23","author":"B Laube","year":"2002","unstructured":"Laube, B., Maksay, G., Schemm, R. & Betz, H. Modulation of glycine receptor function: a novel approach for therapeutic intervention at inhibitory synapses?. Trends Pharm. Sci. 23, 519\u2013527 (2002).","journal-title":"Trends Pharm. Sci."},{"key":"71935_CR4","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1126\/science.aaf8933","volume":"354","author":"C Peirs","year":"2016","unstructured":"Peirs, C. & Seal, R. P. Neural circuits for pain: recent advances and current views. Science 354, 578\u2013584 (2016).","journal-title":"Science"},{"key":"71935_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.neuropharm.2008.07.034","volume":"56","author":"JW Lynch","year":"2009","unstructured":"Lynch, J. W. Native glycine receptor subtypes and their physiological roles. Neuropharmacology 56, 303\u2013309 (2009).","journal-title":"Neuropharmacology"},{"key":"71935_CR6","doi-asserted-by":"publisher","first-page":"7189","DOI":"10.1073\/pnas.89.15.7189","volume":"89","author":"J Guastella","year":"1992","unstructured":"Guastella, J., Brecha, N., Weigmann, C., Lester, H. A. & Davidson, N. Cloning, expression, and localization of a rat brain high-affinity glycine transporter. Proc. Natl. Acad. Sci. USA 89, 7189\u20137193 (1992).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"71935_CR7","doi-asserted-by":"publisher","first-page":"22802","DOI":"10.1016\/S0021-9258(18)41598-0","volume":"268","author":"QR Liu","year":"1993","unstructured":"Liu, Q. R., L\u00f3pez-Corcuera, B., Mandiyan, S., Nelson, H. & Nelson, N. Cloning and expression of a spinal cord- and brain-specific glycine transporter with novel structural features. J. Biol. Chem. 268, 22802\u201322808 (1993).","journal-title":"J. Biol. Chem."},{"key":"71935_CR8","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/325529a0","volume":"325","author":"JW Johnson","year":"1987","unstructured":"Johnson, J. W. & Ascher, P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325, 529\u2013531 (1987).","journal-title":"Nature"},{"key":"71935_CR9","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nature01497","volume":"422","author":"Y Nong","year":"2003","unstructured":"Nong, Y. et al. Glycine binding primes NMDA receptor internalization. Nature 422, 302\u2013307 (2003).","journal-title":"Nature"},{"key":"71935_CR10","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1523\/JNEUROSCI.15-05-03952.1995","volume":"15","author":"F Zafra","year":"1995","unstructured":"Zafra, F. et al. Glycine transporters are differentially expressed among CNS cells. J. Neurosci. 15, 3952\u20133969 (1995).","journal-title":"J. Neurosci."},{"key":"71935_CR11","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1111\/j.1460-9568.1995.tb01125.x","volume":"7","author":"F Zafra","year":"1995","unstructured":"Zafra, F., Gomeza, J., Olivares, L., Arag\u00f3n, C. & Gim\u00e9nez, C. Regional distribution and developmental variation of the glycine transporters GLYT1 and GLYT2 in the rat CNS. Eur. J. Neurosci. 7, 1342\u20131352 (1995).","journal-title":"Eur. J. Neurosci."},{"key":"71935_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1113\/jphysiol.2004.068858","volume":"559","author":"A Brada\u00efa","year":"2004","unstructured":"Brada\u00efa, A., Schlichter, R. & Trouslard, J. Role of glial and neuronal glycine transporters in the control of glycinergic and glutamatergic synaptic transmission in lamina X of the rat spinal cord. J. Physiol. 559, 169\u2013186 (2004).","journal-title":"J. Physiol."},{"key":"71935_CR13","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0896-6273(03)00673-1","volume":"40","author":"J Gomeza","year":"2003","unstructured":"Gomeza, J. et al. Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality. Neuron 40, 797\u2013806 (2003).","journal-title":"Neuron"},{"key":"71935_CR14","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.bbrc.2006.07.080","volume":"348","author":"V Eulenburg","year":"2006","unstructured":"Eulenburg, V. et al. Mutations within the human GLYT2 (SLC6A5) gene associated with hyperekplexia. Biochem Biophys. Res. Commun. 348, 400\u2013405 (2006).","journal-title":"Biochem Biophys. Res. Commun."},{"key":"71935_CR15","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1124\/jpet.108.136267","volume":"326","author":"K Morita","year":"2008","unstructured":"Morita, K. et al. Spinal antiallodynia action of glycine transporter inhibitors in neuropathic pain models in mice. J. Pharm. Exp. Ther. 326, 633\u2013645 (2008).","journal-title":"J. Pharm. Exp. Ther."},{"key":"71935_CR16","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1212\/01.wnl.0000259085.61898.9e","volume":"68","author":"MP Jensen","year":"2007","unstructured":"Jensen, M. P., Chodroff, M. J. & Dworkin, R. H. The impact of neuropathic pain on health-related quality of life: review and implications. Neurology 68, 1178\u20131182 (2007).","journal-title":"Neurology"},{"key":"71935_CR17","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1021\/jm0011272","volume":"44","author":"WL Caulfield","year":"2001","unstructured":"Caulfield, W. L. et al. The first potent and selective inhibitors of the glycine transporter type 2. J. Med Chem. 44, 2679\u20132682 (2001).","journal-title":"J. Med Chem."},{"key":"71935_CR18","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1124\/jpet.122.001265","volume":"382","author":"BS Wilson","year":"2022","unstructured":"Wilson, B. S. et al. Peripheral administration of selective glycine transporter-2 inhibitor, oleoyl-(D)-lysine, reverses chronic neuropathic pain but not acute or inflammatory pain in male mice. J. Pharm. Exp. Ther. 382, 246\u2013255 (2022).","journal-title":"J. Pharm. Exp. Ther."},{"key":"71935_CR19","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1213\/ANE.0000000000000388","volume":"119","author":"N Motoyama","year":"2014","unstructured":"Motoyama, N. et al. Relief of cancer pain by glycine transporter inhibitors. Anesth. Analg. 119, 988\u2013995 (2014).","journal-title":"Anesth. Analg."},{"key":"71935_CR20","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1021\/acs.jmedchem.8b01775","volume":"62","author":"SN Mostyn","year":"2019","unstructured":"Mostyn, S. N. et al. Development of an N-Acyl amino acid that selectively inhibits the glycine transporter 2 to produce analgesia in a rat model of chronic pain. J. Med. Chem. 62, 2466\u20132484 (2019).","journal-title":"J. Med. Chem."},{"key":"71935_CR21","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/bph.12343","volume":"170","author":"A Mingorance-Le Meur","year":"2013","unstructured":"Mingorance-Le Meur, A. et al. Reversible inhibition of the glycine transporter GlyT2 circumvents acute toxicity while preserving efficacy in the treatment of pain. Br. J. Pharm. 170, 1053\u20131063 (2013).","journal-title":"Br. J. Pharm."},{"key":"71935_CR22","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1021\/acschemneuro.9b00655","volume":"11","author":"SN Mostyn","year":"2020","unstructured":"Mostyn, S. N. et al. Photoswitchable ORG25543 congener enables optical control of glycine transporter 2. ACS Chem. Neurosci. 11, 1250\u20131258 (2020).","journal-title":"ACS Chem. Neurosci."},{"key":"71935_CR23","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.drudis.2012.01.003","volume":"17","author":"MH Pang","year":"2012","unstructured":"Pang, M. H., Kim, Y., Jung, K. W., Cho, S. & Lee, D. H. A series of case studies: practical methodology for identifying antinociceptive multi-target drugs. Drug Discov. Today 17, 425\u2013434 (2012).","journal-title":"Drug Discov. Today"},{"key":"71935_CR24","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1093\/pm\/pnab066","volume":"22","author":"I Song","year":"2021","unstructured":"Song, I. et al. Role of VVZ-149, a novel analgesic molecule, in the affective component of pain: results from an exploratory proof-of-concept study of postoperative pain following laparoscopic and robotic-laparoscopic gastrectomy. Pain. Med. 22, 2037\u20132049 (2021).","journal-title":"Pain. Med."},{"key":"71935_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2021.110576","volume":"76","author":"SS Nedeljkovic","year":"2022","unstructured":"Nedeljkovic, S. S. et al. Exploratory study of VVZ-149, a novel analgesic molecule, in the affective component of acute postoperative pain after laparoscopic colorectal surgery. J. Clin. Anesth. 76, 110576 (2022).","journal-title":"J. Clin. Anesth."},{"key":"71935_CR26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nature03978","volume":"437","author":"A Yamashita","year":"2005","unstructured":"Yamashita, A., Singh, S. K., Kawate, T., Jin, Y. & Gouaux, E. Crystal structure of a bacterial homologue of Na+\/Cl-dependent neurotransmitter transporters. Nature 437, 215\u2013223 (2005).","journal-title":"Nature"},{"key":"71935_CR27","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41586-022-04814-x","volume":"606","author":"Z Motiwala","year":"2022","unstructured":"Motiwala, Z. et al. Structural basis of GABA reuptake inhibition. Nature 606, 820\u2013826 (2022).","journal-title":"Nature"},{"key":"71935_CR28","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41586-024-07810-5","volume":"633","author":"W Ji","year":"2024","unstructured":"Ji, W. et al. Substrate binding and inhibition mechanism of norepinephrine transporter. Nature 633, 473\u2013479 (2024).","journal-title":"Nature"},{"key":"71935_CR29","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41586-024-07804-3","volume":"632","author":"JC Nielsen","year":"2024","unstructured":"Nielsen, J. C. et al. Structure of the human dopamine transporter in complex with cocaine. Nature 632, 678\u2013685 (2024).","journal-title":"Nature"},{"key":"71935_CR30","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nature17629","volume":"532","author":"JA Coleman","year":"2016","unstructured":"Coleman, J. A., Green, E. M. & Gouaux, E. X-ray structures and mechanism of the human serotonin transporter. Nature 532, 334\u2013339 (2016).","journal-title":"Nature"},{"key":"71935_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60967-z","volume":"16","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. Dimerization and substrate recognition of human taurine transporter. Nat. Commun. 16, 6163 (2025).","journal-title":"Nat. Commun."},{"key":"71935_CR32","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/S0263-7855(97)00009-X","volume":"14","author":"OS Smart","year":"1996","unstructured":"Smart, O. S., Neduvelil, J. G., Wang, X., Wallace, B. A. & Sansom, M. S. HOLE: a program for the analysis of the pore dimensions of ion channel structural models. J. Mol. Graph 14, 354\u2013360376 (1996).","journal-title":"J. Mol. Graph"},{"key":"71935_CR33","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1023\/A:1012328300037","volume":"26","author":"LG Harsing Jr.","year":"2001","unstructured":"Harsing, L. G. Jr., Solyom, S. & Salamon, C. The role of glycineB binding site and glycine transporter (GlyT1) in the regulation of [3H]GABA and [3H]glycine release in the rat brain. Neurochem Res 26, 915\u2013923 (2001).","journal-title":"Neurochem Res"},{"key":"71935_CR34","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/sj.bjp.0703100","volume":"129","author":"E N\u00fa\u00f1ez","year":"2000","unstructured":"N\u00fa\u00f1ez, E., L\u00f3pez-Corcuera, B., Mart\u00ednez-Maza, R. & Arag\u00f3n, C. Differential effects of ethanol on glycine uptake mediated by the recombinant GLYT1 and GLYT2 glycine transporters. Br. J. Pharm. 129, 802\u2013810 (2000).","journal-title":"Br. J. Pharm."},{"key":"71935_CR35","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1021\/acschemneuro.7b00407","volume":"9","author":"JE Carland","year":"2018","unstructured":"Carland, J. E. et al. Molecular Determinants for Substrate Interactions with the Glycine Transporter GlyT2. ACS Chem. Neurosci. 9, 603\u2013614 (2018).","journal-title":"ACS Chem. Neurosci."},{"key":"71935_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/neuro.02.001.2008","volume":"1","author":"RJ Harvey","year":"2008","unstructured":"Harvey, R. J. et al. A critical role for glycine transporters in hyperexcitability disorders. Front Mol. Neurosci. 1, 1 (2008).","journal-title":"Front Mol. Neurosci."},{"key":"71935_CR37","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/ng1814","volume":"38","author":"MI Rees","year":"2006","unstructured":"Rees, M. I. et al. Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease. Nat. Genet. 38, 801\u2013806 (2006).","journal-title":"Nat. Genet."},{"key":"71935_CR38","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1111\/jnc.16028","volume":"168","author":"RC Chater","year":"2024","unstructured":"Chater, R. C. et al. The efficacy of the analgesic GlyT2 inhibitor, ORG25543, is determined by two connected allosteric sites. J. Neurochem. 168, 1973\u20131992 (2024).","journal-title":"J. Neurochem."},{"key":"71935_CR39","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1021\/acschemneuro.0c00602","volume":"12","author":"C Benito-Mu\u00f1oz","year":"2021","unstructured":"Benito-Mu\u00f1oz, C. et al. Structural Determinants of the Neuronal Glycine Transporter 2 for the Selective Inhibitors ALX1393 and ORG25543. ACS Chem. Neurosci. 12, 1860\u20131872 (2021).","journal-title":"ACS Chem. Neurosci."},{"key":"71935_CR40","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pharmthera.2009.03.018","volume":"123","author":"T Dohi","year":"2009","unstructured":"Dohi, T., Morita, K., Kitayama, T., Motoyama, N. & Morioka, N. Glycine transporter inhibitors as a novel drug discovery strategy for neuropathic pain. Pharm. Ther. 123, 54\u201379 (2009).","journal-title":"Pharm. Ther."},{"key":"71935_CR41","doi-asserted-by":"publisher","first-page":"e0157583","DOI":"10.1371\/journal.pone.0157583","volume":"11","author":"N Subramanian","year":"2016","unstructured":"Subramanian, N. et al. Identification of a 3rd Na+ binding site of the glycine transporter, GlyT2. PLoS One 11, e0157583 (2016).","journal-title":"PLoS One"},{"key":"71935_CR42","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1046\/j.1471-4159.1998.71052211.x","volume":"71","author":"B L\u00f3pez-Corcuera","year":"1998","unstructured":"L\u00f3pez-Corcuera, B. et al. Differential properties of two stably expressed brain-specific glycine transporters. J. Neurochem. 71, 2211\u20132219 (1998).","journal-title":"J. Neurochem."},{"key":"71935_CR43","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1085\/jgp.201912318","volume":"151","author":"FA Erdem","year":"2019","unstructured":"Erdem, F. A. et al. A comparison of the transport kinetics of glycine transporter 1 and glycine transporter 2. J. Gen. Physiol. 151, 1035\u20131050 (2019).","journal-title":"J. Gen. Physiol."},{"key":"71935_CR44","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0896-6273(00)80901-0","volume":"25","author":"MJ Roux","year":"2000","unstructured":"Roux, M. J. & Supplisson, S. Neuronal and glial glycine transporters have different stoichiometries. Neuron 25, 373\u2013383 (2000).","journal-title":"Neuron"},{"key":"71935_CR45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.bbrc.2022.01.056","volume":"594","author":"W Guo","year":"2022","unstructured":"Guo, W., Wang, M. & Chen, L. A co-expression vector for baculovirus-mediated protein expression in mammalian cells. Biochem. Biophys. Res. Commun. 594, 69\u201373 (2022).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"71935_CR46","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.str.2006.01.013","volume":"14","author":"T Kawate","year":"2006","unstructured":"Kawate, T. & Gouaux, E. Fluorescence-detection size-exclusion chromatography for precrystallization screening of integral membrane proteins. Structure 14, 673\u2013681 (2006).","journal-title":"Structure"},{"key":"71935_CR47","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"71935_CR48","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"71935_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsb.2015.11.003","volume":"193","author":"K Zhang","year":"2016","unstructured":"Zhang, K. Gctf: real-time CTF determination and correction. J. Struct. Biol. 193, 1\u201312 (2016).","journal-title":"J. Struct. Biol."},{"key":"71935_CR50","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/s41592-019-0575-8","volume":"16","author":"T Bepler","year":"2019","unstructured":"Bepler, T. et al. Positive-unlabeled convolutional neural networks for particle picking in cryo-electron micrographs. Nat. Methods 16, 1153\u20131160 (2019).","journal-title":"Nat. Methods"},{"key":"71935_CR51","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.cell.2020.11.043","volume":"184","author":"N Wang","year":"2021","unstructured":"Wang, N. et al. Structural basis of human monocarboxylate transporter 1 inhibition by anti-cancer drug candidates. Cell 184, 370\u2013383.e313 (2021).","journal-title":"Cell"},{"key":"71935_CR52","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"},{"key":"71935_CR53","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/pro.3235","volume":"27","author":"TD Goddard","year":"2018","unstructured":"Goddard, T. D. et al. UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Sci. 27, 14\u201325 (2018).","journal-title":"Protein Sci."},{"key":"71935_CR54","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D. Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"71935_CR55","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1107\/S2059798318006551","volume":"74","author":"PV Afonine","year":"2018","unstructured":"Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. D. Struct. Biol. 74, 531\u2013544 (2018).","journal-title":"Acta Crystallogr. D. Struct. Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71935-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71935-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71935-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:06:12Z","timestamp":1781654772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71935-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["71935"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-71935-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5321"}}